skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection

Review

(6432) Views  (804) Full article downloads

Authors: Pranav Dalal, Monica Grafals, Darshika Chhabra, Lorenzo Gallon

Published Date January 2009 Volume 2009:5 Pages 139 - 149
DOI: http://dx.doi.org/10.2147/TCRM.S3068

Pranav Dalal1, Monica Grafals2, Darshika Chhabra2, Lorenzo Gallon2

1Department of Medicine, Mount Sinai Hospital, Chicago, USA; 2Northwestern University–Feinberg School of Medicine, Chicago, USA

Abstract: Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is an inhibitor of inosine monophosphate dehydrogenase (IMPDH). It preferentially inhibits denovo pathway of guanosine nucleotide synthesis in T and B-lymphocytes and prevents their proliferation, thereby suppresses both cell mediated and humoral immune responses. Clinical trials in kidney transplant recipients have shown the efficacy of MMF in reducing the incidence and severity of acute rejection episodes. It also improves long term graft function as well as graft and patient survival in kidney transplant recipients. MMF is useful as a component of toxicity sparing regimens to reduce or avoid exposure of steroids or calcineurin inhibitor (CNI). Enteric-coated mycophenolate sodium (EC-MPS) can be used as an alternative immunosuppressive agent in kidney transplant recipients with efficacy and safety profile similar to MMF.

Keywords: mycophenolate mofetil, kidney transplantation, acute rejection, toxicity sparing






 

Other articles by Dr Lorenzo Gallon



Readers of this article also read:

Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
Anesthesiologists’ perception of patients’ anxiety under regional anesthesia
Everolimus-eluting stents: update on current clinical studies
Phenotype characterization of embryoid body structures generated by a crystal comet effect tail in an intercellular cancer collision scenario